Global API sourcing simplified
We connect API buyers and suppliers worldwide with speed, trust, and full transparency.

Filters

Filters
Filter
Custom request?
Type
Production region
Qualifications
Show more
Country of origin
Show more

Faropenem API Manufacturers & Suppliers

2 verified results
Take control of your API sourcing
Submit a Special Inquiry and have Pharmaoffer activate verified suppliers.

Commercial-scale Suppliers

Distributor
Produced in  India
|

Employees: 25

|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
FDA
|
MSDS
|
BSE/TSE
|
ISO9001

All certificates

GMP
FDA
MSDS
BSE/TSE
ISO9001
CoA
Distributor
Produced in  World
|

Employees: 50

|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
USDMF
|
MSDS
|
ISO9001
|
CoA

All certificates

GMP
USDMF
MSDS
ISO9001
CoA
Take control of your API sourcing
Submit a Special Inquiry and have Pharmaoffer activate verified suppliers.
Get full market intelligence report
Get full market intelligence report
€399,-
All Faropenem data. Full access. Full negotiation power
When insight is your advantage
Full data, full access, full negotiation power
Total market transparency Total market transparency
|
Supplier trade data access Supplier trade data access
|
Buyer / supplier flow comparison Buyer / supplier flow comparison
Trusted by 30,000+ registered pharma professionals:
Reach multinationals, SMEs, compounding pharmacies & more!
Procaps
Pfizer
Reckitt
Sanofi
Blau
Abbvie

Faropenem | CAS No: 106560-14-9 | GMP-certified suppliers

A medication that targets infectious diseases including tuberculosis and community-acquired pneumonia, providing potential antibacterial treatment within systemic antiinfective therapies.

Therapeutic categories

AmidesAntibacterials for Systemic UseAntiinfectives for Systemic UseHeterocyclic Compounds, Fused-RingLactamsSulfur Compounds
Generic name
Faropenem
Molecule type
small molecule
CAS number
106560-14-9
DrugBank ID
DB12190
Approval status
Investigational drug
ATC code
J01DI03

Product Snapshot

  • Faropenem is an oral small molecule antibiotic
  • It is primarily indicated for bacterial infections requiring beta-lactamase resistant agents
  • The compound is currently in investigational status and not approved by major regulatory agencies such as the FDA or EMA

Clinical Overview

Faropenem (CAS Number 106560-14-9) is a synthetic antibacterial agent classified within the beta-lactam family, structurally characterized by a fused-ring lactam and sulfur-containing heterocyclic system. It belongs to the chemical class of alpha amino acids and derivatives, indicating the presence of an amino group attached to the alpha carbon adjacent to a carboxylate moiety.

Clinically, faropenem has been investigated as a potential therapeutic agent in the treatment of infectious diseases such as tuberculosis, including pulmonary tuberculosis, and community-acquired pneumonia. Its usage has predominantly been explored in clinical trials, currently without established global regulatory approvals for general clinical use.

Although detailed pharmacodynamic data and explicit mechanism of action have not been fully elucidated in publicly available sources, faropenem’s classification within the beta-lactam antibiotics suggests a likely mechanism involving inhibition of bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs). This mechanism disrupts peptidoglycan cross-linking leading to bactericidal effects against susceptible pathogens.

Pharmacokinetic parameters including absorption, distribution, metabolism, and excretion (ADME) profiles have not been comprehensively characterized in the available literature. Safety and toxicity profiles require further clinical investigation, as current data originate primarily from investigational contexts and early-phase trials.

From a pharmaceutical sourcing perspective, faropenem is identified under multiple chemical classes including amides and heterocyclic compounds with sulfur atoms, which may influence synthetic pathways and quality control testing. Procurement of faropenem active pharmaceutical ingredient (API) should emphasize stringent adherence to international quality standards such as Good Manufacturing Practice (GMP) and regulatory compliance, with robust impurity profiling and batch-to-batch consistency critical due to its investigational status and structural complexity.

Identification & chemistry

Generic name Faropenem
Molecule type Small molecule
CAS 106560-14-9
UNII F52Y83BGH3
DrugBank ID DB12190

Formulation & handling

  • Faropenem is a small molecule drug suitable for oral formulations due to its moderate water solubility and low logP value.
  • As an alpha amino acid derivative, Faropenem requires consideration of potential stability issues related to amino acid functionality during formulation.
  • Handling should ensure protection from moisture and temperature extremes to maintain compound integrity throughout processing and storage.

Regulatory status

Faropenem is a type of Other substances


The pharmaceutical industry encompasses a diverse range of active pharmaceutical ingredients (APIs) that are used in the production of various medications. One category of APIs is known as other substances. This category includes substances that do not fall under the conventional classifications such as antibiotics, analgesics, or antihypertensives.

Other substances in pharmaceutical APIs consist of a broad array of chemical compounds with unique properties and applications. These substances play a crucial role in the formulation and development of specialized medications, catering to specific therapeutic needs. The category encompasses various substances like excipients, solvents, stabilizers, and pH adjusters.

Excipients are inert substances that aid in the manufacturing process and enhance the stability, bioavailability, and patient acceptability of pharmaceutical formulations. Solvents are used to dissolve other ingredients and facilitate their incorporation into the final product. Stabilizers ensure the integrity and shelf life of medications by preventing degradation or chemical changes. pH adjusters help maintain the desired pH level of a formulation, which can influence the drug's efficacy and stability.

Pharmaceutical manufacturers carefully select and incorporate specific other substances into their formulations, adhering to regulatory guidelines and quality standards. These substances undergo rigorous testing and evaluation to ensure their safety, efficacy, and compatibility with the desired pharmaceutical product. By employing other substances in API formulations, pharmaceutical companies can optimize drug delivery, improve patient compliance, and enhance therapeutic outcomes.

In summary, the other substances category of pharmaceutical APIs comprises a diverse range of chemicals, including excipients, solvents, stabilizers, and pH adjusters. These substances contribute to the formulation, stability, and performance of medications, enabling pharmaceutical manufacturers to develop specialized products that meet specific therapeutic requirements.

Faropenem API manufacturers & distributors

Compare qualified Faropenem API suppliers worldwide. We currently have 2 companies offering Faropenem API, with manufacturing taking place in 2 different countries. Use the table below to review supplier type, countries of origin, certifications, product portfolio and GMP audit availability.

SupplierTypeCountryProduct originCertificationsPortfolio
Distributor
Germany World CoA, GMP, GDP, MSDS, USDMF243 products
Distributor
India India BSE/TSE, CoA, FDA, GMP, ISO9001, MSDS484 products

When sending a request, specify which Faropenem API quality you need: for example EP (Ph. Eur.), USP, JP, BP, or another pharmacopoeial standard, as well as the required grade (base, salt, micronised, specific purity, etc.).

Use the list above to find high-quality Faropenem API suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our help page to learn more about sourcing APIs via Pharmaoffer.